Abstract
Monogenic inflammasomopathies constitute a group of rheumatological disorders stemming from dysregulation of the inflammasome complex caused by gain-of-function mutations in inflammasome genes or molecules that indirectly affect its activation. The prototypes of this group of diseases are the Cryopyrin-Associated Periodic Syndrome (CAPS) and Familial Mediterranean Fever (FMF), associated …